STOCK Sirt3tm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:06779 |
International strain name | STOCK Sirt3tm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0496_2_F10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Sirt3tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Sirt3 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0496_2_F10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac |
Breeding at archiving centre | Chimeras were mated to C57BL/6NTac and maintained on this genetic background. Due to the use of the C57BL/6N-Atm1Brd/a ES cells, agouti and non-agouti offspring may be generated. |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased circulating LDL cholesterol level / MGI
- increased circulating triglyceride level / MGI
- hyperglycemia / MGI
- liver inflammation / MGI
- increased circulating insulin level / MGI
- abnormal lipid homeostasis / MGI
- no abnormal phenotype detected / MGI
- hepatic steatosis / MGI
- no phenotypic analysis / MGI
- liver fibrosis / MGI
- increased circulating VLDL cholesterol level / MGI
- increased circulating cholesterol level / MGI
- decreased oxygen consumption / MGI
- abnormal enzyme/coenzyme level / MGI
- insulin resistance / MGI
- abnormal cell physiology / MGI
- increased susceptibility to diet-induced obesity / MGI
- increased systemic arterial systolic blood pressure / MGI
- increased circulating tumor necrosis factor level / MGI
- increased circulating interferon-gamma level / MGI
- increased circulating interleukin-10 level / MGI
- increased circulating interleukin-6 level / MGI
- increased circulating interleukin-12 level / MGI
- abnormal cytokine level / MGI
- decreased carbon dioxide production / MGI
- increased liver triglyceride level / MGI
- increased total body fat amount / MGI
- increased liver cholesterol level / MGI
- mortality/aging / MGI
- abnormal cellular respiration / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).